B2DB — Who said what, where, and when

The DACMAR Advantage: This approach helps biotech companies position themselves for potential acquisition or public offering, with a focus on creating sustainable impact and preparing for long-term success

Orphan Drugs & Rare Diseases Global Congress Europe 2025 · 19 March 2025 · 10:10 · Auditorium 1

The DACMAR Advantage: This approach helps biotech companies position themselves for potential acquisition or public offering, with a focus on creating sustainable impact and preparing for long-term success was a session at Orphan Drugs & Rare Diseases Global Congress Europe 2025 on 19 March 2025 in London, with 1 speaker on record.

Speakers